Flow Cytometry Detection of Medium-Term Macrophages for Biomarker and Phenotype Analysis and Panel Design

Medium term macrophages represent a transitional macrophage subset classified according to inflammatory progression, cellular lifespan, and differentiation stage. This population is exclusively present during the subacute phase of pathological injury, infection and post-surgical tissue repair, whereas it is barely detectable under physiological steady-state conditions in intact tissues. Flow cytometry technology could be applied for the identification and analysis.

Table of Contents

1. Key features and biological functions of medium-term macrophages

2. Biomarkers and phenotypic identification of medium-term macrophages

3. Flow cytometry panel design for medium-term macrophage detection

01 Key features and biological functions of medium-term macrophages

1.1 Core function of medium term macrophage

Medium term macrophage acts as an indispensable regulatory hub linking inflammatory resolution and tissue remodeling, and occupies a transitional position between short-lived pro-inflammatory M1 macrophages (acute inflammatory phase) and long-lived tissue-resident macrophages.

1.2 Key features of medium term macrophage

Unique origin, life cycle, phenotype and regulatory function had been proved in medium term macrophage. These cells originate solely from bone marrow-derived Ly6C+ circulating monocytes that infiltrate injured tissues and undergo local differentiation, rather than embryonic tissue-resident precursors. The cells persist for 1-4 weeks, with peak abundance observed at 3–14 days post-injury, which coincides with the key time frame for investigating tissue repair processes. Meanwhile, the subset displays a mixed M1 and M2 transitional phenotype characterized by attenuated pro-inflammatory activity, robust anti-inflammatory capacity and pronounced reparative plasticity.

Medium term macrophages terminate acute inflammatory cascades, clear apoptotic tissue debris and promote angiogenesis. Conversely, sustained aberrant retention of this population may exacerbate tissue fibrosis and aggravate pathological lesions.

02 Biomarkers and phenotypic identification of medium-term macrophages

No single unique biomarker can specifically label intermediate macrophages. The analytical workflow relies on a three-layer hierarchical gating strategy: pan-macrophage lineage markers to isolate total macrophage populations, ontogenic markers to distinguish monocyte-derived infiltrating macrophages from embryonic resident macrophages, and polarization gradient markers to define transitional functional states. This framework effectively eliminates population misclassification and false-positive signals.

2.1 Core biomarkers analysis

Lineage markers (CD11b, F4/80): Dual-positive gating criteria specific to murine macrophages, which exclude contaminating lymphocytes, granulocytes and stromal cells to precisely resolve total macrophage populations.

Ontogenic discriminator (Ly6C): The definitive marker for cellular origin. Ly6C positivity identifies monocyte-derived infiltrating macrophages (the exclusive progenitor pool of intermediate macrophages), while Ly6C negativity denotes embryonic-derived steady-state resident macrophages.

Polarization gradient marker (CD206): The primary biomarker for functional subtyping; cellular functional status is stratified based on differential CD206 expression intensity.

2.2 Definitive phenotype

The phenotype of CD11b⁺ F4/80⁺ Ly6C⁺ CD206low can be used for medium term macrophage identification.

2.3 Critical Notes for Flow Cytometric Data Interpretation

Binary stratification must be avoided, as medium term macrophages constitute a dynamic transitional cell state without absolute positive/negative expression cutoffs. Fluorescence intensity gradients of surface biomarkers serve as the sole standard for population identification.

Ly6C must not be ignored as the omission of Ly6C stratification will erroneously assign steady-state resident macrophages to the medium term macrophage population, thereby introducing substantial analytical bias.

Table 1. Comparative Profiling of Three Major Macrophages

03 Flow cytometry panel design for medium-term macrophage detection

A validated fluorochrome panel compatible with standard 2-laser, 6-channel flow cytometers is provided below for murine tissue specimens (liver, lung, and other parenchymal organs).

Table 2. Valid panel design for medium term macrophage identification

Reference:

[1] Dalmas E, Clement K. Dynamic macrophage polarization and intermediate states in tissue repair and inflammation[J]. Frontiers in Immunology, 2021, 12: 712689.

[2] Wang X, et al. Infiltrating Ly6C+ monocyte-derived macrophages drive the subacute repair phase via a CD206low intermediate phenotype[J]. Cellular & Molecular Immunology, 2022, 19(8): 921-930.

[3] Pinto A R, et al. Macrophage heterogeneity in tissue injury and regeneration[J]. Nature Reviews Immunology, 2020, 20(5): 302-317.

[4] Olingy C E, et al. Ly6Chi monocyte transition to Ly6Clo repair macrophages governs wound healing kinetics[J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 2018, 38(4): 824-836.

[5] Li Y, et al. Dynamic profiling of macrophage intermediate states during inflammatory resolution[J]. Journal of Immunology Research, 2023, 2023: 1-12.

[6] Tidball J G, et al. Distinct macrophage subpopulations regulate sequential stages of tissue repair[J]. Matrix Biology, 2019, 81: 56-68.

[7] Li S, et al. Hepatic monocyte-derived macrophage subsets defined by Ly6C and CD206 orchestrate liver inflammation and fibrosis progression[J]. International Journal of Molecular Sciences, 2024, 25(8): 4562.